In vitro activity of cefovecin, extended-spectrum cephalosporin, against 284 clinical isolates collected from cats and dogs in Croatia

被引:0
|
作者
Seol, Branka [1 ]
Matanovic, Kresimir
Mekic, Selma
Staresina, Vilim
机构
[1] Univ Zagreb, Dept Microbiol, Zagreb 10000, Croatia
关键词
cefovecin; antimicrobial susceptibility; disk-diffusion; Staphylococcus pseudintermedius; E; coli; Proteus spp; EFFICACY; SAFETY; PHARMACOKINETICS; INFECTIONS;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
During the six-month collection period, 284 bacterial strains were recovered from different clinical samples from cats and dogs. Susceptibility to cefovecin was determined by disk-diffusion method. Out of 284 bacterial isolates, 202 were gram-positive bacteria and 82 were gram-negative. The most frequently isolated bacterial species was gram-positive Staphylococcus pseudintermedius (152), followed by streptococci (50). The most common gram-negative bacteria were Pseudomonas aeruginosa (26), Proteus spp. (25) and E. coli (22). The highest resistance among gram-positive bacteria was observed in non-hemolytic streptococci (50%) and Staphylococcus pseudintermedius (7.2%). Beta-hemolytic streptococci were 100% sensitive to cefovecin. As expected, cefovecin did not show any activity against P aeruginosa. Besides that, the highest resistance was shown by E. coli (40.9%) and Proteus spp. (8%). All P multocida isolates were sensitive to cefovecin. The results of the conducted survey show no significant differences of cefovecin activity against beta-hemolytic streptococci and P multocida isolates from EU and USA compared to Croatian strains, when tested by the broth microdilution and disk-diffusion method. However, resistance rates in S. pseudintermedius, E. coli and Panel's spp. are much higher among the Croatian strains.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [1] Antimicrobial activity and spectrum of cefovecin, a new extended-spectrum cephalosporin, against pathogens collected from dogs and cats in Europe and North America
    Stegemann, M. R.
    Passmore, C. A.
    Sherington, J.
    Lindeman, C. J.
    Papp, G.
    Weigel, D. J.
    Skogerboe, T. L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2286 - 2292
  • [2] Effectiveness and safety of cefovecin sodium, an extended-spectrum injectable cephalosporin, in the treatment of cats with abscesses and infected wounds
    Six, Robert
    Cleaver, Dawn M.
    Lindeman, Cindy J.
    Cherni, Judith
    Chesebrough, Robert
    Papp, Georg
    Skogerboc, Terry L.
    Weigel, Dan J.
    Boucher, Joseph F.
    Stegemann, Michael R.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2009, 234 (01): : 81 - 87
  • [3] Prevalence and mechanisms of extended-spectrum cephalosporin resistance in clinical and fecal Enterobacteriaceae isolates from dogs in Ontario, Canada
    Zhang, Pauline L. C.
    Shen, Xiao
    Chalmers, Gabhan
    Reid-Smith, Richard J.
    Slavic, Durda
    Dick, Hani
    Boerlin, Patrick
    VETERINARY MICROBIOLOGY, 2018, 213 : 82 - 88
  • [4] In Vitro Activity of Plant Extracts and Alkaloids against Clinical Isolates of Extended-Spectrum β-Lactamase (ESBL)-Producing Strains
    Zuo, Guo-Ying
    Meng, Fan-Yan
    Han, Jun
    Hao, Xiao-Yan
    Wang, Gen-Chun
    Zhang, Yun-Ling
    Zhang, Qing
    MOLECULES, 2011, 16 (07) : 5453 - 5459
  • [5] Extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia
    Bedenic, B
    Zagar, Z
    JOURNAL OF CHEMOTHERAPY, 1998, 10 (06) : 449 - 459
  • [6] In vitro efficacy of cephamycins against multiple extended-spectrum β-lactamase-producing Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter cloacae isolates from dogs and cats
    Kusumoto, Mizuki
    Kanao, Yuka
    Narita, Haruka
    Jitsuiki, Makoto
    Iyori, Keita
    Tsunoi, Manami
    Tsuyuki, Yuzo
    Torii, Kae
    Harada, Kazuki
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2023, 85 (06): : 653 - 656
  • [7] Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli
    Sorlozano, Antonio
    Gutierrez, Jose
    Romero, Jose Maria
    Luna, Juan de Dios
    Damas, Miguel
    Pidrola, Gonzalo
    JOURNAL OF BASIC MICROBIOLOGY, 2007, 47 (05) : 413 - 416
  • [8] In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study
    Silva-Sanchez, Jesus
    Reyna-Flores, Fernando
    Elena Velazquez-Meza, Ma.
    Rojas-Moreno, Teresa
    Benitez-Diaz, Arturo
    Sanchez-Perez, Alejandro
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 70 (02) : 270 - 273
  • [9] High Prevalence of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae Among Clinical Isolates From Cats and Dogs Admitted to a Veterinary Hospital in Switzerland
    Zogg, Anna Lena
    Simmen, Sabrina
    Zurfluh, Katrin
    Stephan, Roger
    Schmitt, Sarah N.
    Nuesch-Inderbinen, Magdalena
    FRONTIERS IN VETERINARY SCIENCE, 2018, 5
  • [10] Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum β-lactamase-producing Enterobacteriaceae
    Lu, Chin-Te
    Chuang, Yin-Ching
    Sun, Wu
    Liu, Yung-Ching
    Cheng, Yu-Jen
    Lu, Po-Liang
    Chen, Chih-Ming
    Hsu, Gwo-Jong
    Jang, Tsrang-Neng
    Lee, Chun-Ming
    Chiang, Ping-Cherng
    Shi, Zhi-Yuan
    Wang, Lih-Shinn
    Kung, Hsiang-Chi
    Lin, Hsiu-Chen
    Liao, Chun-Hsing
    Liu, Jien-Wei
    Huang, Cheng-Hua
    Tsao, Shih-Ming
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S179 - S183